|
|
???tair.name??? >
???browser.page.title.author???
|
"lin zong zhe"???jsp.browse.items-by-author.description???
Showing items 1-19 of 19 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 臺大學術典藏 |
2018-09-10T07:19:44Z |
Nuclear overexpression of mitotic regulatory proteins in biliary tract cancer: Correlation with clinicopathologic features and patient survival
|
Shen, Y.-C. and Hu, F.-C. and Jeng, Y.-M. and Chang, Y.-T. and Lin, Z.-Z. and Chang, M.-C. and Hsu, C. and Cheng, A.-L.; 沈盈君;胡賦強;鄭永銘;張毓廷;林宗哲;章明珠;許駿;鄭安理; SHEN, YING-CHUN;HU, FU-CHANG;JENG, YUNG-MING;CHANG, YU-TING;LIN, ZONG-ZHE;CHANG, MING-CHU;HSU, CHIUN;CHENG, ANN-LII; YUNG-MING JENG; YU-TING CHANG; ANN-LII CHENG; SHEN, YING-CHUN; HU, FU-CHANG; JENG, YUNG-MING; CHANG, YU-TING; LIN, ZONG-ZHE; CHANG, MING-CHU; HSU, CHIUN; CHENG, ANN-LII |
| 國立臺灣大學 |
2011 |
Phase Ii Study of Low-Dose Everolimus Plus Weekly Cisplatin and 24-Hour Infusion of High-Dose 5-Fluorouracil and Leucovorin for First-Line Treatment of Metastatic or Recurrent Gastric Cancers
|
葉坤輝; 沈盈君; 林育麟; 林宗哲; 陳立宗; 趙毅; 鄭安理; YEH, KUN-HUEI; SHEN, YING-CHUN; LIN, YU-LIN; LIN, ZONG-ZHE; CHEN, LI-TZONG; CHAO, YEE; CHENG, ANN-LII |
| 國立臺灣大學 |
2010 |
A Randomized, Double-Blind, Parallel, Comparative Study to Evaluate the Efficacy and Safety of Ramosetron Plus Dexamethasone Injection for the Prevention of Acute Chemotherapy-Induced Nausea and Vomiting
|
何景良; 蘇五洲; 謝瑞坤; 林宗哲; 趙祖怡; HO, CHING-LIANG; SU, WU-CHOU; HSIEH, RUEY-KUN; LIN, ZONG-ZHE; CHAO, TSU-YI |
| 國立臺灣大學 |
2010 |
Chemotherapy Response in East Asian Non-Small Cell Lung Cancer Patients Harboring Wild-Type or Activating Mutation of Epidermal Growth Factor Receptors
|
林家齊; 徐心馨; 孫家棟; 施金元; 林宗哲; 余忠仁; 楊志新; LIN, CHIA-CHI; HSU, HSIN-HSIN; SHUN, CHIA-TUNG; SHIH, JIN-YUAN; LIN, ZONG-ZHE; YU, CHONG-JEN; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2010 |
Early Alpha-Fetoprotein Response Predicts Treatment Efficacy of Antiangiogenic Systemic Therapy in Patients with Advanced Hepatocellular Carcinoma
|
邵幼雲; 林宗哲; 許駿; 沈盈君; 徐志宏; 鄭安理; SHAO, YU-YUN; LIN, ZONG-ZHE; HSU, CHIUN; SHEN, YING-CHUN; HSU, CHIH-HUNG; CHENG, ANN-LII |
| 國立臺灣大學 |
2010 |
Efficacy and Tolerability of Bevacizumab Plus Capecitabine as First-Line Therapy in Patients with Advanced Hepatocellular Carcinoma
|
徐志宏; 許駿; 陳培哲; 林宗哲; 趙祖怡; 鄭安理; HSU, CHIH-HUNG; HSU, CHIUN; CHEN, PEI-JER; LIN, ZONG-ZHE; CHAO, TSU-YI; CHENG, ANN-LII |
| 國立臺灣大學 |
2010 |
Hepatic Arterial Infusion of Chemotherapy for Advanced Hepatocellular Carcinoma
|
邵幼雲; 黃俊傑; 梁博欽; 林宗哲; SHAO, YU-YUN; HUANG, CHUN-CHIEH; LIANG, PO-CHIN; LIN, ZONG-ZHE |
| 國立臺灣大學 |
2010 |
Phase Ii Study of Combining Sorafenib with Metronomic Tegafur/Uracil for Advanced Hepatocellular Carcinoma
|
徐志宏; 沈盈君; 林宗哲; 陳培哲; 邵幼雲; 丁雅慧; 許駿; 鄭安理; HSU, CHIH-HUNG; SHEN, YING-CHUN; LIN, ZONG-ZHE; CHEN, PEI-JER; SHAO, YU-YUN; DING, YEA-HUI; HSU, CHIUN; CHENG, ANN-LII |
| 國立臺灣大學 |
2010 |
Significance of Aurora B Overexpression in Hepatocellular Carcinoma. Aurora B Overexpression in Hcc
|
林宗哲; 鄭永銘; 胡賦强; 潘弘偉; 賴寶蓮; 李伯皇; 鄭安理; 許輝吉; LIN, ZONG-ZHE; JENG, YUNG-MING; HU, FU-CHANG; PAN, HUNG-WEI; LAI, PO-LIN; LEE, PO-HUANG; CHENG, ANN-LII; HSU, HEY-CHI |
| 國立臺灣大學 |
2009 |
Nuclear Overexpression of Mitotic Regulatory Proteins in Biliary Tract Cancer: Correlation with Clinicopathologic Features and Patient Survival
|
沈盈君; 胡賦強; 鄭永銘; 張毓廷; 林宗哲; 章明珠; 許駿; 鄭安理; SHEN, YING-CHUN; HU, FU-CHANG; JENG, YUNG-MING; CHANG, YU-TING; LIN, ZONG-ZHE; CHANG, MING-CHU; HSU, CHIUN; CHENG, ANN-LII |
| 國立臺灣大學 |
2009 |
Sunitinib-Induced Myxedema Coma
|
陳世英; 高培傑; 林宗哲; 江文莒; 方震中; CHEN, SHEY-YING; KAO, PEI-CHIEH; LIN, ZONG-ZHE; CHIANG, WEN-CHU; FANG, CHENG-CHUNG |
| 國立臺灣大學 |
2009 |
A Phase Ii Study of Sorafenib in Combination with Tegafur/Uracil (Uft) for Asian Patients with Advanced Hepatocellular Carcinoma (Hcc)
|
沈盈君; 許駿; 徐志宏; 林宗哲; 陳培哲; 邵幼雲; 丁雅慧; 鄭安理; SHEN, YING-CHUN; HSU, CHIUN; HSU, CHIH-HUNG; LIN, ZONG-ZHE; CHEN, PEI-JER; SHAO, YU-YUN; DING, YEA-HUI; CHENG, ANN-LII |
| 國立臺灣大學 |
2009 |
A Phase Ii Trial of Thalidomide Plus Tegafur/Uracil for Patients with Advanced/Metastatic Hepatocellular Carcinoma (Hcc): Final Report
|
徐志宏; 林宗哲; 沈盈君; 許駿; 鄭安理; HSU, CHIH-HUNG; LIN, ZONG-ZHE; SHEN, YING-CHUN; HSU, CHIUN; CHENG, ANN-LII |
| 國立臺灣大學 |
2009 |
Egfr Intron 1 Dinucleotide Repeat Polymorphism Is Associated with the Occurrence of Skin Rash with Gefitinib Treatment
|
黃敬倫; 楊志新; 葉坤輝; 胡賦强; 陳冠宇; 施金元; 林宗哲; 余忠仁; 鄭安理; 楊泮池; HUANG, CHING-LUN; YANG, CHIH-HSIN; YEH, KUN-HUEI; HU, FU-CHANG; CHEN, KUAN-YU; SHIH, JIN-YUAN; LIN, ZONG-ZHE; YU, CHONG-JEN; CHENG, ANN-LII; YANG, PAN-CHYR |
| 國立臺灣大學 |
2009 |
Gastric Perforation Presenting as Empyema in a Patient with Pancreatic Cancer on Bevacizumab Treatment
|
邵幼雲; 林宗哲; 梁博欽; 田郁文; 鄭安理; SHAO, YU-YUN; LIN, ZONG-ZHE; LIANG, PO-CHIN; TIEN, YU-WEN; CHENG, ANN-LII |
| 國立臺灣大學 |
2009 |
Prognostic Factors of Survival in 236 Advanced Hepatocellular Carcinoma Patients Enrolled in Prospective Clinical Trials of Systemic Therapy
|
林宗哲; 邵幼雲; 徐志宏; 許駿; 洪瑞隆; 鄭安理; LIN, ZONG-ZHE; SHAO, YU-YUN; HSU, CHIH-HUNG; HSU, CHIUN; HONG, RUEY-LONG; CHENG, ANN-LII |
| 國立臺灣大學 |
2009 |
Quality of Life in Advanced Non-Small Cell Lung Cancer Patients Receiving First-Line Gefitinib Monotherapy
|
邵幼雲; 林宗哲; 胡賦强; 余忠仁; 施金元; 胡文郁; 張逸良; 鄭安理; 楊泮池; 楊志新; SHAO, YU-YUN; LIN, ZONG-ZHE; HU, FU-CHANG; YU, CHONG-JEN; SHIH, JIN-YUAN; HU, WEN-YU; CHANG, YIH-LEONG; CHENG, ANN-LII; YANG, PAN-CHYR; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2008 |
Expression of Mitosis Regulatory Proteins in Biliary Tract Carcinoma: Correlation with Clinico-Pathological Features and Patient Outcome
|
沈盈君; 胡賦強; 鄭永銘; 張玉憲; 林宗哲; 張明志; 許駿; 鄭安理; SHEN, YING-CHUN; HU, FU-CHANG; JENG, YUNG -MING; CHANG, YU-SHIAHN; LIN, ZONG-ZHE; CHANG, MING-CHIH; HSU, CHIUN; CHENG, ANN-LII |
| 國立臺灣大學 |
2008 |
Phase Ii Study of Sorafenib Plus Tegafur/Uracil (Uft) in Patients with Advanced Hepatocellular Carcinoma (Hcc)
|
沈盈君; 邵幼雲; 徐志宏; 許駿; 林宗哲; 陳培哲; 丁雅慧; 鄭安理; SHEN, YING-CHUN; SHAO, YU-YUN; HSU, CHIH-HUNG; HSU, CHIUN; LIN, ZONG-ZHE; CHEN, PEI-JER; DING, YEA-HUI; CHENG, ANN-LII |
Showing items 1-19 of 19 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
